MDMA could be available as treatment in USA as early as 2024 following recent trial

MDMA could be available as a treatment in US hospitals as early as 2024 after a successful trial containing 90 patients with severe PTSD found two-thirds of participants were “cured” after being treated with the drug.

During the trial, participants were given either a placebo, 80mg or 120mg doses of MDMA before undertaking 90-minute sessions with a therapist to talk about their experiences. Patients also wore eye masks and were played music while they sat with researchers to see how they reacted, before being given a smaller booster dose of 40-60mg around two hours into the treatment.

The trial yielded staggering results, with 88% of participants having significant improvements in their symptoms after their third therapy session, with two-thirds (67%) no longer showing enough symptoms to be diagnosed as having PTSD.

Researchers will now begin the process of gaining drug approval from the US Food and Drug Administration (FDA), which could happen as soon as the next 12 months, according to Mail Online.